Pharmaceutical care for severe and critically ill patients with COVID-19 / 浙江大学学报·医学版
Journal of Zhejiang University. Medical sciences
;
(6): 158-169, 2020.
Artículo
en Chino
| WPRIM
| ID: wpr-828558
ABSTRACT
Severe and critically ill patients with coronavirus disease 2019 (COVID-19) were usually with underlying diseases, which led to the problems of complicated drug use, potential drug-drug interactions and medication errors in special patients. Based on ( 6), and -19 , we summarized the experience in the use of antiviral drugs, corticosteroids, vascular active drugs, antibacterial, probiotics, nutrition support schemes in severe and critically ill COVID-19 patients. It is also suggested to focus on medication management for evaluation of drug efficacy and duration of treatment, prevention and treatment of adverse drug reactions, identification of potential drug-drug interactions, individualized medication monitoring based on biosafety protection, and medication administration for special patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Antivirales
/
Neumonía Viral
/
Enfermedad Crítica
/
Corticoesteroides
/
Infecciones por Coronavirus
/
Apoyo Nutricional
/
Probióticos
/
Usos Terapéuticos
/
Quimioterapia
/
Pandemias
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Zhejiang University. Medical sciences
Año:
2020
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS